Washington · Nonprofit
Chris Elliott Fund End Brain Cancer Initiative
Chris Elliott Fund End Brain Cancer Initiative (Washington) receives grants from 7 organizations whose IRS filings report $205,053 to it, the largest being Tillery Family Foundation ($106,000). 3 of them have funded it in more than one year.
- Revenue FY2024
- $529k
- Funders on record
- 7
- Grants received
- $205k
- Net assets
- $8k
What Chris Elliott Fund End Brain Cancer Initiative does
Mission
The EndBrainCancer Initiative | Chris Elliott Fund is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, FDA-approved treatments, specialists and clinical trials. We believe that IMMEDIATE ACCESS to these options provides the patient community with the best HOPE for survival and sustained quality of life. We advocate for policy and care improvements while echoing the patients voice in clinical trial protocol. We partner with industry, patients, researchers, advocacy groups, medical teams, hospital networks and others to educate patients and their caregivers with a focus on next generation sequencing so they can have empowered conversations with medical teams
As stated on its FY2024 Form 990.
Programs
On its FY2023 return the organization reported starting a significant new program.
We started to work on contracts for consulting on clinical trial protocols, etc. With some specific organizations.
Its own explanation, from Schedule O of that return (Part III, line 2).
Disease education/awareness/outreach program: patient disease education, awareness and outreach of disease via creation of educational materials that are housed on our website as well as provided to the brain tumor community via digital and social media, disease educational online meetings/events, patient roundtables, on-on-one email interactions, in-person, zoom meetings, facetime, small group meetings, speaking engagements, live streaming on facebook, creation of educational videos, fact sheets, content and articles via large scale distribution through our media partners. In 2023, ebci provided over 18 million opportunities to educate patients, caregivers, families, industry and the general public via the above efforts.
$299,991 spent60% of program spendingDirect connect patient program & services: ebci directly and personally connects patients, caregivers & families to top brain tumor specialists for 2nd/3rd/4th opinions, surgery and treatment options and to principal investigators, clinical trials and translational medicine. Ebci currently has 7500+ touch points per month and opportunities to educate and directly serve over 900 patients, caregivers and families annually on a one-on-one basis including case management.
$124,996 spent25% of program spendingBrain tumor patient advocacy and access program: consult on the creation of clinical trial protocols and policy that incorporates the 'patient voice'. Work with insurance companies and medicare to increase coverage of treatment options and reimbursement amounts for fda approved treatments. Collaborate with other brain tumor organizations to advance treatment options for brain tumors, brain cancer, and metastasized disease to the brain community.
$74,998 spent$31,422 earned by the program15% of program spending
The 3 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $499,985.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $90k to $14k (−84%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
95% of Chris Elliott Fund End Brain Cancer Initiative’s revenue is contributions — more donation-reliant than the typical peer (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 5 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Dellann Elliott Mydland
President & CEO
As listed on its FY2024 Form 990.
The chief executive listed changed between the FY2021 and FY2022 filings.
Who funds it, year by year
2018 → 2023: the base narrowed from 3 funders to 1 funder, grant income fell $24k → $20k.
6 of 7 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 48% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of Chris Elliott Fund End Brain Cancer Initiative’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
Chris Elliott Fund End Brain Cancer Initiative leans on a few funders — its largest provides 52% of grant income and the top three 77%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
48% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund Chris Elliott Fund End Brain Cancer Initiative.
Largest funder’s share by year: 2018 42% · 2019 100% · 2020 100% · 2021 100% · 2022 100% · 2023 100% — growing more concentrated.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
Chris Elliott Fund End Brain Cancer Initiative draws 100% of its grant income from funders outside Washington, across 1 state in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $99k arriving through sponsors registered in 6 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
Chris Elliott Fund End Brain Cancer Initiative receives grants from 7 organizations whose IRS filings report $205k to it.
this organization peer median middle 50% of peers· 13,754 health nonprofits $100k–$1M, FY2024
Organizations like Chris Elliott Fund End Brain Cancer Initiative
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Washington
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
81% of spending goes to programs.
Governance
Public support
51%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for Chris Elliott Fund End Brain Cancer Initiative: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds Chris Elliott Fund End Brain Cancer Initiative?
- Chris Elliott Fund End Brain Cancer Initiative (Washington) receives grants from 7 organizations whose IRS filings report $205,053 to it, the largest being Tillery Family Foundation ($106,000). 3 of them have funded it in more than one year.
- How many funders does Chris Elliott Fund End Brain Cancer Initiative have?
- IRS filings report 7 organizations giving $205,053 in grants to Chris Elliott Fund End Brain Cancer Initiative, 3 of which have funded it in more than one year.
- Who is the largest funder of Chris Elliott Fund End Brain Cancer Initiative?
- Tillery Family Foundation is the largest funder on record, with $106,000 in grants. The full list of funders is on this page.
- How can an organization like Chris Elliott Fund End Brain Cancer Initiative find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Washington. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 7 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing